Products 1239908-20-3
CAS 1239908-20-3 appears in our catalog under these names: Ixazomib citrate/ 98.37% (existing batch purity), Ixazomibe citrate, Ixazomib citrate [MLN9708], Ixazomib citrate 98%, Ixazomib citrate, 97%, 97%. Offered by: TargetMol, Biosynth, Chemat, Ambeed, MedChemExpress. Available pack sizes: 5mg, 10mg, 25mg, 50mg, 100mg, 500mg, 1g, 1mg.
Ixazomib citrate is a glycine derivative that is the amide obtained by formal condensation of the carboxy group of N-(2,5-dichlorobenzoyl)glycine with the amino group of 2,2'-{2-[(1R)-1-amino-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid. A prodrug for ixazomib that is used in combination therapy for treatment of multiple myeloma. It has a role as an antineoplastic agent, a prodrug, a proteasome inhibitor, an apoptosis inducer and an orphan drug. It is a member of benzamides, a dichlorobenzene, a glycine derivative, an oxo dicarboxylic acid and a 1,3,2-dioxaborolane. It is functionally related to an ixazomib.
Source: ChEBI
| Molecular formula | C20H23BCl2N2O9 |
|---|---|
| Molecular weight | 517.1 g/mol |
| IUPAC name | 2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid |
| InChIKey | MBOMYENWWXQSNW-AWEZNQCLSA-N |
| SMILES | B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl |
Computed by PubChem (NCBI)